phentermine-topiramate
Selected indexed studies
- Phentermine/Topiramate: Pediatric First Approval. (Paediatr Drugs, 2022) [PMID:36059008]
- Phentermine-Topiramate. (, 2012) [PMID:31644252]
- Obesity Management in Adults: A Review. (JAMA, 2023) [PMID:38015216]
_Worker-drafted node — pending editorial review._
Connections
phentermine-topiramate is a side effect of
Sources
- Phentermine/Topiramate: Pediatric First Approval. (2022) pubmed
- Obesity Management in Adults: A Review. (2023) pubmed
- Medications for Obesity: A Review. (2024) pubmed
- AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. (2022) pubmed
- Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome. (2021) pubmed
- Phentermine-Topiramate. (2012) pubmed
- Phentermine/topiramate for the treatment of obesity. (2013) pubmed
- A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity. (2023) pubmed
- Obesity in Adolescents: A Review. (2024) pubmed
- Obesity: Pathophysiology and Management. (2018) pubmed